<DOC>
	<DOCNO>NCT01470612</DOCNO>
	<brief_summary>This study open label , long-term extension study subject moderate severe ulcerative colitis design evaluate long term therapy CP-690,550 .</brief_summary>
	<brief_title>Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects complete induction study A3921094 A3921095 classify meet clinical response criterion ; OR Subjects complete maintenance study A3921096 discontinue treatment early Study A3921096 due treatment failure . Subjects major protocol violation Study A3921094 , A3921095 A3921096 . Presence indeterminate colitis , microscopic colitis , ischemic colitis , infectious colitis , clinical finding suggestive Crohn 's disease . Subjects surgery ulcerative colitis opinion investigator , likely require surgery ulcerative colitis study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>open-label</keyword>
	<keyword>long term treatment</keyword>
</DOC>